Sourced evidence
GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding
Source extract: "GSK will maintain its 78.3% majority owned economic interest." "As a result of this transaction, Shionogi will increase its economic interest in ViiV Healthcare to 21.7%."
- Source
- GSK
- Type
- Company filing or release
- Published
- January 20, 2026
- Confidence
- 90/100
- Filed under
- ViiV Healthcare
Supports these links
Cite this
InsightNodes, "GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding" (ViiV Healthcare). Source: GSK, January 20, 2026, https://www.gsk.com/en-gb/media/press-releases/gsk-pfizer-and-shionogi-agree-on-changes-to-viiv-healthcare-shareholding/. https://insightnodes.com/claims/e/viiv-healthcare-p4-gsk-shareholding-2026 (accessed November 10, 2026).
This page has a permanent address — link to it from notes, articles or models. Not investment advice.